Paul J. Clancy, Executive VP and CFO at BIOGEN INC. (BIIB), sold 9,892 shares at $290.00 ($2.9M) on 2017-04-25, disclosed to the SEC on 2017-04-27.
Open-market sale of $2.9M BIIB by Executive VP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |
| BIIB | SELL | 2013-09-19 | $6.6M | — | Filing → |